1α,25-Dihydroxyvitamin D3 (calcitriol) and its analogue, 19-nor-1α,25(OH)2D2, potentiate the effects of ionising radiation on human prostate cancer cells

British Journal of Cancer

Volumn 89, Issue 4, 2003, Pages 746-753

  Dunlap, N ^a   Schwartz, G G ^a   Eads, D ^a   Cramer, S D ^a   Sherk, A B ^a   John, V ^a   Koumenis, C ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Radiosensitizer; Synergistic; Vitamin D; Zemplar

Indexed keywords

BIOLOGICAL RESPONSE MODIFIER; CALCITRIOL; CALCITRIOL DERIVATIVE; PARICALCITOL; DNA; ERGOCALCIFEROL; RADIOSENSITIZING AGENT;

APOPTOSIS; ARTICLE; BEAM THERAPY; BLADDER FUNCTION; BRACHYTHERAPY; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER LOCALIZATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG METABOLISM; DRUG POTENTIATION; HUMAN; HUMAN CELL; INTESTINE FUNCTION; IONIZING RADIATION; MORBIDITY; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RELAPSE; CELL CULTURE; CELL DIVISION; CHEMISTRY; COMPARATIVE STUDY; GENETICS; MALE; PATHOLOGY; PROSTATE TUMOR; RADIATION EXPOSURE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CALCITRIOL; CELL DIVISION; DNA, NEOPLASM; ERGOCALCIFEROLS; HUMANS; MALE; PROSTATIC NEOPLASMS; RADIATION, IONIZING; RADIATION-SENSITIZING AGENTS; TUMOR CELLS, CULTURED;

EID: 0043236062     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601161     Document Type: Article

References (58)

1. Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P (2000) Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control 11: 847-852
2. Asou H, Koike M, Elstner E, Cambell M, Le J, Uskokovic MR, Kamada N, Koeffler HP (1998) 19-nor vitamin-D analogues: a new class of potent inhibitors of proliferation and inducers of differentiation of human myeloid leukemia cell lines. Blood 92: 2441-2449
3. Barreto AM, Schwartz GG, Woodruff R, Cramer SD (2000) 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells. Cancer Epidemiol Biomarkers Prev 9: 265-270
4. Bill CA, Garrett KC, Harrell R, Tofilon PJ (1992a) Enhancement of radiation-induced cell killing and DNA double-strand breaks in a human tumor cell line using nanomolar concentrations of aclacinomycin A. Radiat Res 129: 315-321
5. Bill CA, Grochan BM, Vrdoljak E, Mendoza EA, Tofilon PJ (1992b) Decreased repair of radiation-induced DNA double-strand breaks with cellular differentiation. Radiat Res 132: 254-258
6. Billis W, Fuks Z, Kolesnick R (1998) Signaling in and regulation of ionizing radiation-induced apoptosis in endothelial cells. Recent Prog Horm Res 53: 85-92, discussion 93
7. Blutt SE, Polek TC, Stewart LV, Kattan MW, Weigel NL (2000) A calcitriol analog, EB1089, inhibits the growth of LNCaP tumors in nude mice. Cancer Res 60: 779-782
8. Blutt SE, Weigel NL (1999) Vitamin D and prostate cancer. Proc Soc Exp Biol Med 221: 89-98
9. Bolla M, Collette L, Blank L, Warde P, Dubois JB, Mirimanoff RO, Storme G, Bernier J, Kuten A, Sternberg C, Mattelaer J, Lopez Torecilla J, Pfeffer JR, Lino Cutajar C, Zurlo A, Pierart M (2002) Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet 360: 103-106
10. Brown JM, Wouters BG (1999) Apoptosis, p53, and tumor cell sensitivity to anticancer agents. Cancer Res 59: 1391-1399
11. Brown JM, Wouters BG (2001) Apoptosis: mediator or mode of cell killing by anticancer agents? Drug Resist Update 4: 135-136
12. Campbell MJ, Elsmer E, Holden S, Uskokovic M, Koeffler HP (1997) Inhibition of proliferation of prostate cancer cells by a 19-norhexafluoride vitamin D3 analog involves the induction of p21waf1, p27kip1 and E-cadherin. J Mol Endocrinol 19: 15-27
13. Campbell MJ, Koeffler HP (1997) Toward therapeutic intervention of cancer by vitamin D compounds. J Natl Cancer Inst 89: 182-185
14. Chen TC, Schwartz GG, Burnstein KL, Lokeshwar BL, Holick M.F (2000) The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer. Clin Cancer Res 6: 901-908
15. Chou T (1974) Relationships between inhibition constants and fractional inhibition in enzyme-catalyzed reactions with different numbers of reactants, different reaction mechanisms, and different types and mechanisms of inhibition. Mol Pharmacol 10: 235-247
16. Chou TC, Talalay P (1984) Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22: 27-55
17. Ding HF, Fisher DE (2001) p53, caspase 8, and regulation of apoptosis after ionizing radiation. J Pediatr Hematol Oncol 23: 185-188
18. Eisman IA, Koga M, Sutherland RL, Barkla DH, Turton PJ (1989) 1,25-Dihydroxyvitamin D3 and the regulation of human cancer cell replication. Proc Soc Exp Biol Med 191: 221-226
19. Feldman D, Zhao XY, Krishnan AV (2000) Vitamin D and prostate cancer. Endocrinology 141: 5-9
20. Fuks Z, Leibel SA, Wallner KE, Begg CB, Fair WR, Anderson LL, Hilaris BS, Whitmore WF (1991) The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation. Int J Radiat Oncol Biol Phys 21: 537-547
21. Garnick MB, Fair WR (1998) Combating prostate cancer. Sci Am 279: 74-83
22. Godyn JJ, Xu H, Zhang F, Kolla S, Studzinski GP (1994) A dual block to cell cycle progression in HL60 cells exposed to analogs of vitamin D3. Cell Prolif 27: 37-46
23. Hamilton AS, Stanford JL, Gilliland FD, Albertsen PC, Stephenson RA, Hoffman RM, Eley JW, Harlan LC, Potosky AL (2001) Health outcomes after external-beam radiation therapy for clinically localised prostate cancer: results from the Prostate Cancer Outcomes Study. J Clin Oncol 19: 2517-2526
24. Hansen CM, Binderup L, Hamberg KJ, Carlberg C (2001) Vitamin D and cancer: effects of 1,25(OH)2D3 and its analogues on growth control and tumorigenesis. Front Biosci 6: D820-D848
25. Hoffmann W, Blase MA, Santo-Hoeltje L, Herskind C, Bamberg M, Rodemann HP (1999) Radiation sensitivity of human squamous cell carcinoma cells in vitro is modulated by all-trans and 13-cis-retinoic acid in combination with interferon-alpha. Int J Radiat Oncol Biol Phys 45: 991-998
26. James SY, Mercer E, Brady M, Binderup L, Colston KW (1998) EB1089, a synthetic analogue of vitamin D, induces apoptosis in breast cancer cells in vivo and in vitro. Br J Pharmacol 125: 953-962
27. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ (2003) Cancer statistics, 2003. CA Cancer J Clin 53: 5-26
28. Keely FX, Gomella LG (1998) Epidemiology of Prostate Cancer. In Prostate Cancer, Ernstoff MS, Heany JA, Peschel RE (eds) pp 2-14. London: Blackwell Sciences
29. Liu G, Oettel K, Ripple G, Staab MJ, Horvath D, Alberti D, Arzoomanian R, Marnocha R, Bruskewitz R, Mazess R, Bishop C, Bhattacharya A, Bailey H, Wilding G (2002) Phase I trial of 1alpha-hydroxyvitamin D(2) in patients with hormone refractory prostate cancer. Clin Cancer Res 8: 2820-2827
30. Lokeshwar BL, Schwartz GG, Selzer MG, Burnstein KL, Zhuang SH, Block NL, Binderup L (1999) Inhibition of prostate cancer metastasis in vivo: a comparison of 1,25-dihydroxyvitamin D (calcitriol) and EB1089. Cancer Epidemiol Biomarkers Prev 8: 241-248
31. Luscombe CJ, Fryer AA, French ME, Liu S, Saxby MF, Jones PW, Strange RC (2001) Exposure to ultraviolet radiation: association with susceptibility and age at presentation with prostate cancer. Lancet 358: 641-642
32. McGuire TF, Trump DL, Johnson CS (2001) Vitamin D(3)-induced apoptosis of murine squamous cell carcinoma cells. Selective induction of caspase-dependent MEK cleavage and up-regulation of MEKK-1. J Biol Chem 276: 26365-26373
33. Miller AC, Whittaker T, Thibault A, Samid D (1997) Modulation of radiation response of human tumour cells by the differentiation inducers, phenylacetate and phenylbutyrate. Int J Radiat Biol 72: 211-218
34. Miller GJ, Stapleton GE, Ferrara JA, Lucia MS, Pfister S, Hedlund TE, Upadhya P (1992) The human prostatic carcinoma cell line LNCaP expresses biologically active, specific receptors for 1 alpha,25-dihydroxyvitamin D3. Cancer Res 52: 515-520
35. Moffatt KA, Johannes WU, Miller GJ (1999) 1Alpha,25dihydroxyvitamin D3 and platinum drugs act synergistically to inhibit the growth of prostate cancer cell lines. Clin Cancer Res 5: 695-703
36. Narvaez CJ, Zinser G, Welsh J (2001) Functions of 1alpha,25-dihydroxyvitamin D(3) in mammary gland: from normal development to breast cancer. Steroids 66: 301-308
37. Nias A (1988) Clinical Radiobiology. New York: Churchill Livingstone
38. Peehl DM, Skowronski RJ, Leung GK, Wong ST, Stamey TA, Feldman D (1994) Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells. Cancer Res 54: 805-810
39. Peehl DM, Stamey TA (1986) Serum-free growth of adult human prostatic epithelial cells. In Vitro Cell Dev Biol 22: 82-90
40. Peehl DM, Wong ST, Stamey TA (1988) Clonal growth characteristics of adult human prostatic epithelial cells. In Vitro Cell Dev Biol 24: 530-536
41. Perez CA (1997) Prostate. In Principles and Practices in Radiation Oncology, Perez CA, Brady LW (eds) pp 1583-1694. Philadelphia: Lippincot-Raven
42. Pirianov G, Danielsson C, Carlberg C, James SY, Colston KW (1999) Potentiation by vitamin D analogues of TNFalpha and ceramide-induced apoptosis in MCF-7 cells is associated with activation of cytosolic phospholipase A2. Cell Death Differ 6: 890-901
43. Platz EA, Hankinson SE, Hollis BW, Colditz GA, Hunter DJ, Speizer FE, Giovannucci E (2000) Plasma 1,25-dihydroxy-and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum. Cancer Epidemiol Biomarkers Prev 9: 1059-1065
44. Pollack A, Zagars GK, Starkschall G, Antolak JA, Lee JJ, Huang E, von Eschenbach AC, Kuban DA, Rosen I (2002) Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53: 1097-1105
45. Ravid A, Rocker D, Machlenkin A, Rotem C, Hochman A, Kessler-Icekson G, Liberman UA, Koren R (1999) 1,25-Dihydroxyvitamin D3 enhances the susceptibility of breast cancer cells to doxorubicin-induced oxidative damage. Cancer Res 59: 862-867
46. Schwartz GG, Hill CC, Oeler TA, Becich MJ, Bahnson RR (1995) 1,25-Dihydroxy-16-ene-23-yne-vitamin D3 and prostate cancer cell proliferation in vivo. Urology 46: 365-369
47. Schwartz GG, Hulka BS (1990) Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res 10: 1307-1311
48. Schwartz GG, Wang MH, Zang M, Singh RK, Siegal GP (1997) 1 alpha,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells. Cancer Epidemiol Biomarkers Prev 6: 727-732
49. Schwartz GG, Whitlatch LW, Chen TC, Lokeshwar B, Holick LMF (1998) Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. Cancer Epidemiol Biomarkers Prev 7: 391-395
50. Seol JG, Park WH, Kim ES, Jung CW, Binderup L, Koeffler HP, Kim BK, Lee YY (2000) Effect of a novel vitamin D3 analog, EB1089, on G1 cell cycle regulatory proteins in HL-60 cells. Int J Oncol 16: 315-320
51. Sheard MA (2001) Ionizing radiation as a response-enhancing agent for CD95-mediated apoptosis. Int J Cancer 96: 213-220
52. Shipley WU, Verhey LJ, Munzenrider JE, Suit HD, Urie MM, McManus PL, Young RH, Shipley JW, Zietman AL, Biggs PJ, Heney NM, Goitein M (1995) Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int J Radiat Oncol Biol Phys 32: 3-12
53. Simboli-Campbell M, Narvaez CJ, van Weelden K, Tenniswood M, Welsh J (1997) Comparative effects of 1,25(OH)2D3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells. Breast Cancer Res Treat 42: 31-41
54. Skowronski RJ, Peehl DM, Feldman D (1995) Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3. Endocrinology 136: 20-26
55. Studzinski GP, McLane JA, Uskokovic MR (1993) Signaling pathways for vitamin D-induced differentiation: implications for therapy of proliferative and neoplastic diseases. Crit Rev Eukaryot Gene Expr 3: 279-312
56. Sundaram S, Gewirtz DA (1999) The vitamin D3 analog EB 1089 enhances the response of human breast tumor cells to radiation. Radiat Res 152: 479-486
57. Welsh J, Simboli-Campbell M, Narvaez CJ, Tenniswood M (1995) Role of apoptosis in the growth inhibitory effects of vitamin D in MCF-7 cells. Adv Exp Med Biol 375: 45-52
58. Zhuang SH, Burnstein KL (1998) Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation. Endocrinology 139: 1197-1207